Aliases & Classifications for Cerebral Hemorrhage

MalaCards integrated aliases for Cerebral Hemorrhage:

Name: Cerebral Hemorrhage 39

Summaries for Cerebral Hemorrhage

MalaCards based summary : Cerebral Hemorrhage is related to cerebral amyloid angiopathy, app-related and cerebral amyloid angiopathy, cst3-related. An important gene associated with Cerebral Hemorrhage is CST3 (Cystatin C), and among its related pathways/superpathways are Neuroscience and Cell adhesion_ECM remodeling. The drugs Aspirin and Probucol have been mentioned in the context of this disorder. Affiliated tissues include brain, heart and bone, and related phenotypes are cardiovascular system and muscle

Related Diseases for Cerebral Hemorrhage

Diseases related to Cerebral Hemorrhage via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 219)
# Related Disease Score Top Affiliating Genes
1 cerebral amyloid angiopathy, app-related 33.8 APP CST3
2 cerebral amyloid angiopathy, cst3-related 33.7 APP CST3
3 hemorrhage, intracerebral 32.5 APP CST3
4 amyloidosis 30.5 APP CST3
5 hereditary cerebral amyloid angiopathy 30.0 APP CST3
6 brain edema 29.9 GFAP MMP9
7 spinal cord injury 29.7 GFAP MMP9
8 cerebrovascular disease 29.6 APOB APP MMP9
9 arteries, anomalies of 29.3 APOB MMP9
10 myocardial infarction 29.2 APOB CST3 MMP9
11 eclampsia 11.4
12 cerebral cavernous malformation, familial 11.2
13 cerebral cavernous malformations 11.0
14 thrombocytopenia 1 11.0
15 binswanger's disease 10.2 APP GFAP
16 alzheimer disease 10.1
17 scrapie 10.1 APP GFAP
18 peripheral artery disease 10.1 APOB CST3
19 stroke, ischemic 10.1
20 thrombosis 10.1
21 endocarditis 10.1
22 aortic aneurysm, familial abdominal, 1 10.1 CST3 MMP9
23 toxic encephalopathy 10.1 APP GFAP
24 vascular dementia 10.1 APP CST3
25 leukoencephalopathy, hereditary diffuse, with spheroids 10.1 APP GFAP
26 leukemia 10.1
27 end stage renal failure 10.0 APOB CST3
28 grade iii astrocytoma 10.0 GFAP MMP9
29 infective endocarditis 10.0
30 carotid artery disease 10.0 APOB MMP9
31 ischemia 10.0
32 encephalitis 10.0
33 brain injury 10.0
34 thrombocytopenia 10.0
35 dementia 10.0
36 gliosarcoma 9.9 GFAP MMP9
37 microvascular complications of diabetes 1 9.9 GFAP MMP9
38 choriocarcinoma 9.9
39 encephalopathy 9.9
40 amyotrophic lateral sclerosis 1 9.9 APP CST3 GFAP
41 nervous system disease 9.9 APP GFAP MMP9
42 central nervous system disease 9.9 APP GFAP MMP9
43 vascular disease 9.8 APOB CST3 MMP9
44 systemic lupus erythematosus 9.8
45 pheochromocytoma 9.8
46 moyamoya disease 1 9.8
47 ocular motor apraxia 9.8
48 acute promyelocytic leukemia 9.8
49 traumatic brain injury 9.8
50 angiosarcoma 9.8

Graphical network of the top 20 diseases related to Cerebral Hemorrhage:



Diseases related to Cerebral Hemorrhage

Symptoms & Phenotypes for Cerebral Hemorrhage

MGI Mouse Phenotypes related to Cerebral Hemorrhage:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.35 APOB APP CST3 GFAP MMP9
2 muscle MP:0005369 9.02 APOB APP CST3 GFAP MMP9

Drugs & Therapeutics for Cerebral Hemorrhage

Drugs for Cerebral Hemorrhage (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 388)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 50-78-2 2244
2
Probucol Approved, Investigational Phase 4 23288-49-5 4912
3
Cilostazol Approved, Investigational Phase 4,Not Applicable 73963-72-1 2754
4
Enoxaparin Approved Phase 4,Phase 3,Phase 2 9005-49-6 772
5
Nicardipine Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 55985-32-5 4474
6
Heparin Approved, Investigational Phase 4,Phase 3,Not Applicable 9005-49-6 46507594 772
7
Dalteparin Approved Phase 4,Phase 2,Not Applicable 9005-49-6
8
Nadroparin Approved, Investigational Phase 4
9
Atracurium Approved, Experimental, Investigational Phase 4 64228-79-1 47319
10
Cisatracurium Approved Phase 4,Not Applicable 96946-41-7
11
Phylloquinone Approved, Investigational Phase 4,Phase 3,Not Applicable,Early Phase 1 84-80-0
12 Menaquinone Approved, Investigational Phase 4,Phase 3,Not Applicable,Early Phase 1 1182-68-9
13
Warfarin Approved Phase 4,Phase 3,Not Applicable 81-81-2 54678486 6691
14
tannic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 1401-55-4
15
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 1994-09-7, 94-09-7 2337
16
Simvastatin Approved Phase 4,Phase 2,Not Applicable 79902-63-9 54454
17
Clevidipine Approved, Investigational Phase 4,Phase 3,Phase 2 167221-71-8
18
Midazolam Approved, Illicit Phase 4,Not Applicable 59467-70-8 4192
19
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
20
Sevoflurane Approved, Vet_approved Phase 4,Not Applicable 28523-86-6 5206
21
Etomidate Approved Phase 4,Not Applicable 33125-97-2 667484 36339
22
Edoxaban Approved Phase 4,Phase 2,Phase 3,Not Applicable 480449-70-5
23
Valproic Acid Approved, Investigational Phase 4 99-66-1 3121
24
Mannitol Approved, Investigational Phase 4,Not Applicable 69-65-8 6251 453
25
Thrombin Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
26
Clopidogrel Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 120202-66-6, 113665-84-2 60606
27
Caffeine Approved Phase 4,Phase 1,Phase 2 58-08-2 2519
28
Sodium Citrate Approved, Investigational Phase 4 68-04-2
29
Ticagrelor Approved Phase 4 274693-27-5 9871419
30
Amlodipine Approved Phase 4,Phase 3,Not Applicable 88150-42-9 2162
31
Angiotensin II Approved, Investigational Phase 4,Phase 3,Not Applicable 11128-99-7, 68521-88-0, 4474-91-3 172198
32
Olmesartan Approved, Investigational Phase 4 144689-24-7, 144689-63-4 158781 130881
33
Ethanol Approved Phase 4,Phase 1,Phase 2,Not Applicable 64-17-5 702
34
Pitavastatin Approved Phase 4 147511-69-1, 147526-32-7 5282452 6366718
35
Ezetimibe Approved Phase 4 163222-33-1 150311
36
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Not Applicable 437-38-7 3345
37
Succinylcholine Approved Phase 4,Not Applicable 306-40-1 5314
38
Atorvastatin Approved Phase 4,Not Applicable 134523-00-5 60823
39
Nitroprusside Approved, Investigational Phase 4,Phase 3,Not Applicable 15078-28-1 11963622
40
Esmolol Approved Phase 4,Phase 3,Not Applicable 103598-03-4, 81147-92-4 59768
41
Nitric Oxide Approved Phase 4,Phase 2,Phase 3,Not Applicable 10102-43-9 145068
42
Betamethasone Approved, Vet_approved Phase 4,Not Applicable 378-44-9 9782
43
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
44
Dexmedetomidine Approved, Vet_approved Phase 4,Not Applicable 113775-47-6 5311068 68602
45
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
46
Desflurane Approved Phase 4 57041-67-5 42113
47
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
48
Losartan Approved Phase 4 114798-26-4 3961
49
Lisinopril Approved, Investigational Phase 4 83915-83-7, 76547-98-3 5362119
50
Tirofiban Approved Phase 4 144494-65-5 60947

Interventional clinical trials:

(show top 50) (show all 547)
# Name Status NCT ID Phase Drugs
1 Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy Unknown status NCT01918722 Phase 4 ICH-1(herbal medicine with Hirudo, Tabanus);placebo;ICH-2(herbal medicine without Hirudo, Tabanus)
2 PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage Unknown status NCT01013532 Phase 4 Cilostazol;Probucol;Aspirin;placebo of cilostazol;placebo of aspirin
3 PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study Unknown status NCT02483169 Phase 4 cilostazol;Probucol;Aspirin;placebo of cilostazol;Placebo of aspirin
4 Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage Unknown status NCT00699465 Phase 4 enoxaparin;enoxaparin placebo
5 IV Double and Triple Concentrated Nicardipine for Stroke and ICH Unknown status NCT00325793 Phase 4 Nicardipine
6 Comparison of Staged Angioplasty and Routine Single-stage Stenting (CAS) in the Treatment of Carotid Artery Stenosis Unknown status NCT02224209 Phase 4
7 Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD Unknown status NCT01531829 Phase 4 Recombinant tissue plasminogen activator (rt-PA);Low Molecular Weight Heparin
8 The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial Unknown status NCT00724724 Phase 4 Butylphthalide Soft Capsules;Aspirin
9 The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris Unknown status NCT02870764 Phase 4 Dan-shen extract;Placebo
10 Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents Unknown status NCT02404779 Phase 4 cisatracurium besilate
11 Seizures Post Intracerebral Hemorrhage Completed NCT01115959 Phase 4 valproic acid;placebo bid
12 Clinical Study on the Treatment of Hypertensive Intracerebral Hemorrhage With Panax Notoginseng Saponin Completed NCT02999048 Phase 4 Panax Notoginseng Saponins
13 International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage Completed NCT00928915 Phase 4 Prothrombin complex concentrate (PCC); fresh frozen plasma (FFP)
14 Low-dose Versus Standard Dose Alteplase in Acute Ischemic Stroke , 4 Monthes Prospective Study Completed NCT03847883 Phase 4 Intravenous Solution Ateplase
15 Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2) Completed NCT00234065 Phase 4 Cilostazol;Aspirin
16 COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke Completed NCT00814268 Phase 4 Clopidogrel;Clopidogrel placebo;Aspirin
17 Temperature Control in Central Fever in the Neuro-ICU Completed NCT00751634 Phase 4
18 Clopidogrel for Acute Ischaemia of Recent Onset Completed NCT02776540 Phase 4 Clopidogrel;Aspirin
19 MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine Completed NCT00809055 Phase 4 Caffeine citrate
20 Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System Completed NCT00197392 Phase 4
21 A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting Completed NCT02330640 Phase 4 ticagrelor;clopidogrel;asprin
22 OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Completed NCT00134160 Phase 4 Olmesartan medoxomil;Calcium channel blockers (amlodipine, azelnidipine)
23 Imaging Guided Patient Selection for Interventional Revascularization Therapy Completed NCT00963989 Phase 4
24 Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT) Completed NCT00301392 Phase 4 Life style interventions plus concomitant use of pitavastatin.
25 Continuous Glucose Monitoring and Preterm Infants Completed NCT02583776 Phase 4
26 Danhong Injection in the Treatment of Acute Ischemic Stroke Completed NCT01677208 Phase 4 Danhong injection;placebo
27 Cilostazol Stroke Prevention Study for Antiplatelet Combination Completed NCT01995370 Phase 4 aspirin;clopidogrel;cilostazol
28 Study of Heart and Renal Protection Completed NCT00125593 Phase 4 Simvastatin 20 mg;Ezetimibe 10mg;Placebo
29 Danhong Injection in the Treatment of Chronic Stable Angina Completed NCT01681316 Phase 4 Danhong injection;Placebo
30 Study of Antithrombotic Treatment After IntraCerebral Haemorrhage Recruiting NCT03186729 Phase 4 Antithrombotic Agent
31 Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®) Recruiting NCT03300479 Phase 4 Clevidipine;Urapidil
32 Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Neurological Improving Trial Recruiting NCT03772847 Phase 4 ginkgolide
33 Intervention for High-normal or Borderline-elevated Blood Pressure in Adults With Type 2 Diabetes Recruiting NCT03264352 Phase 4 Allisartan Isoproxil;Amlodipine 5mg;Hydrochlorothiazide 25 mg;Allisartan Isoproxil placebo;Amlodipine placebo;Hydrochlorothiazide placebo
34 Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke Recruiting NCT03661411 Phase 4 Aspirin;Clopidogrel 75mg;Alteplase
35 SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke Recruiting NCT03263117 Phase 4 Sedation;General Anesthesia (GA)
36 Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism Recruiting NCT03090113 Phase 4 Shuxuetong Injection;Placebo Injection
37 Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD Recruiting NCT03417388 Phase 4 High dose potent statin;ACE-I (lisinopril) or ARB (losartan);Aspirin
38 ASCEND: A Study of Cardiovascular Events iN Diabetes Active, not recruiting NCT00135226 Phase 4 Aspirin;Omega-3 Ethyl Esters;Placebo Aspirin;Placebo Omega-3 Ethyl Esters
39 Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy Not yet recruiting NCT03354026 Phase 4 AICH-PXZY;AICH-without PXZY;AICH-placebo
40 Esmolol for the Treatment of Hypertension After Intracerebral Hemorrhage Study (ETHICHS) Not yet recruiting NCT03743103 Phase 4 Brevibloc, 10 Mg/mL Intravenous Solution;Nitroprusside, Sodium
41 EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF) Not yet recruiting NCT03950076 Phase 4 Edoxaban
42 Early Initiation of Low Dose Tirofiban for Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction Not yet recruiting NCT03797729 Phase 4 Tirofiban;Normal saline
43 Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth Terminated NCT00295464 Phase 4 Betamethasone sodium phos (drug)
44 Forced Fluid Removal in High Risk Acute Kidney Injury Terminated NCT02458157 Phase 4 Furosemide (Furix)
45 The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Withdrawn NCT01042574 Phase 4 Clevidipine butyrate
46 Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From Cerebral Hemorrhage Unknown status NCT00815737 Phase 2, Phase 3 rhubarb;Placebo
47 Pilot Study of Hypothermia for Intracerebral Hemorrhage in Croatia Unknown status NCT01221142 Phase 3
48 Edoxaban for TIA and Acute Minor Stroke Unknown status NCT02221102 Phase 2, Phase 3 Aspirin;edoxaban;placebo
49 Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events Unknown status NCT01923818 Phase 2, Phase 3 rivaroxaban;Aspirin;placebo
50 Clinical Value of Noninvasive Intracranial Pressure Measurement Unknown status NCT02130219 Phase 2, Phase 3

Search NIH Clinical Center for Cerebral Hemorrhage

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Cerebral Hemorrhage cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Cerebral Hemorrhage:
GLP-1 CellBeads, encapsulated mesenchymal stem cells for intracerebral hemorrhage
Embryonic/Adult Cultured Cells Related to Cerebral Hemorrhage:
GLP-transfected mesenchymal stem cells PMIDs: 22985173 22034462

Genetic Tests for Cerebral Hemorrhage

Anatomical Context for Cerebral Hemorrhage

MalaCards organs/tissues related to Cerebral Hemorrhage:

42
Brain, Heart, Bone, Lung, Testes, Kidney, Bone Marrow

Publications for Cerebral Hemorrhage

Articles related to Cerebral Hemorrhage:

(show top 50) (show all 686)
# Title Authors Year
1
Generation of 3 human induced pluripotent stem cell lines LUMCi005-A, B and C from a Hereditary Cerebral Hemorrhage with Amyloidosis-Dutch type patient. ( 30611017 )
2019
2
Tristetraprolin attenuates brain edema in a rat model of cerebral hemorrhage. ( 30729695 )
2019
3
Neutrophil-to-Lymphocyte Ratio in Acute Cerebral Hemorrhage: a System Review. ( 30090954 )
2019
4
Previous chronic symptomatic and asymptomatic cerebral hemorrhage in patients with acute ischemic stroke. ( 30488255 )
2019
5
Time-effect relationship of acupuncture on histopathology, ultrastructure, and neuroethology in the acute phase of cerebral hemorrhage. ( 30531084 )
2019
6
Comparison of keyhole endoscopy and craniotomy for the treatment of patients with hypertensive cerebral hemorrhage. ( 30633227 )
2019
7
Fenobucarb induces heart failure and cerebral hemorrhage in zebrafish. ( 30685545 )
2019
8
Experimental study on the detection of cerebral hemorrhage in rabbits based on broadband antenna technology. ( 30689436 )
2019
9
The safety and efficacy of tPA intravenous thrombolysis for treating acute ischemic stroke patients with a history of cerebral hemorrhage. ( 30698226 )
2019
10
Ultrasonography Monitoring of Optic Nerve Sheath Diameter and Retinal Vessels in Patients with Cerebral Hemorrhage. ( 30714259 )
2019
11
Tranexamic Acid in Cerebral Hemorrhage: A Meta-Analysis and Systematic Review. ( 30741383 )
2019
12
Radial Dislocation of Extensor Tendon Over the Metacarpophalangeal Joint of the Thumb due to Cerebral Hemorrhage: A Case Report. ( 30760160 )
2019
13
Rehabilitation training combined acupuncture for limb hemiplegia caused by cerebral hemorrhage: A protocol for a systematic review of randomized controlled trial. ( 30817621 )
2019
14
Original Intracerebral Hemorrhage Score for the Prediction of Short-Term Mortality in Cerebral Hemorrhage: Systematic Review and Meta-Analysis. ( 30889025 )
2019
15
Clinical Features of Nephrotic Syndrome with Cerebral Hemorrhage. ( 30904921 )
2019
16
Neuroendoscopic minimally invasive surgery and small bone window craniotomy hematoma clearance in the treatment of hypertensive cerebral hemorrhage. ( 31086518 )
2019
17
The biomarkers and potential pathogenesis of lung cancer related cerebral hemorrhage. ( 31096511 )
2019
18
Brain Transcriptomic Analysis of Hereditary Cerebral Hemorrhage With Amyloidosis-Dutch Type. ( 29706885 )
2018
19
TGFβ pathway deregulation and abnormal phospho-SMAD2/3 staining in hereditary cerebral hemorrhage with amyloidosis-Dutch type. ( 28557134 )
2018
20
Theaflavin alleviates inflammatory response and brain injury induced by cerebral hemorrhage via inhibiting the nuclear transcription factor kappa β-related pathway in rats. ( 29928110 )
2018
21
Increased dabigatran plasma concentration during Ibrutinib treatment: a case of cerebral hemorrhage and successful dabigatran reversal by idarucizumab. ( 28447276 )
2018
22
Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. ( 28595677 )
2018
23
Cerebral hemorrhage as the initial manifestation in patients with systemic cancer. ( 28724319 )
2018
24
Fatalities, Cerebral Hemorrhage, and Severe Cardiovascular Toxicity After Exposure to the New Psychoactive Substance 4-Fluoroamphetamine: A Prospective Cohort Study. ( 28969928 )
2018
25
Recurrent Cerebral Hemorrhage in Normal Pregnancy Secondary to Mycotic Pseudoaneurysms Related to Choriocarcinoma. ( 28987845 )
2018
26
Tanshinone I prevents atorvastatin-induced cerebral hemorrhage in zebrafish and stabilizes endothelial cell-cell adhesion by inhibiting VE-cadherin internalization and actin-myosin contractility. ( 29017932 )
2018
27
Response by Fouda and Switzer to Letter Regarding Article, "Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial". ( 29183950 )
2018
28
Letter by Chang et al Regarding Article, "Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial". ( 29183951 )
2018
29
Mixed-location cerebral hemorrhage/microbleeds: Underlying microangiopathy and recurrence risk. ( 29247070 )
2018
30
Hypertensive Cerebral Hemorrhage in a Patient with Turner Syndrome Caused by Deletion in the Short Arm of the X Chromosome. ( 29275412 )
2018
31
Anticoagulants Resumption after Warfarin-Related Intracerebral Haemorrhage: The Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy). ( 29433151 )
2018
32
Fatal cerebral hemorrhage in a tetraplegic patient due to autonomic dysreflexia triggered by delay in emptying urinary bladder after unsuccessful intermittent catheterization by carer: lessons learned. ( 29563843 )
2018
33
A case of Cardiobacterium valvarum endocarditis with cerebral hemorrhage after MVR, TVP and vegetation removal operation. ( 29566704 )
2018
34
Nerve growth factor in combination with Oxiracetam in the treatment of Hypertensive Cerebral Hemorrhage. ( 29643882 )
2018
35
Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets. ( 29737222 )
2018
36
Cerebral Venous Sinus Thrombosis with Cerebral Hemorrhage Presenting with Status Epilepticus in Early Pregnancy. ( 29739085 )
2018
37
Glioblastoma multiforme subterfuge as acute cerebral hemorrhage: A case report and literature review. ( 29844891 )
2018
38
Relationship Between Short Term Variability (STV) and Onset of Cerebral Hemorrhage at Ischemia-Reperfusion Load in Fetal Growth Restricted (FGR) Mice. ( 29867536 )
2018
39
Lethal cerebral hemorrhage after ticagrelor intoxication: a specific antidote is urgently needed. ( 29889575 )
2018
40
Related Factors of Early Mortality in Young Adults with Cerebral Hemorrhage. ( 29915811 )
2018
41
Pharmacokinetics and pharmacodynamics of linezolid in plasma/cerebrospinal fluid in patients with cerebral hemorrhage after lateral ventricular drainage by Monte Carlo simulation. ( 29928111 )
2018
42
Influence of tranexamic acid on cerebral hemorrhage: A meta-analysis of randomized controlled trials. ( 29929173 )
2018
43
Fetal cerebral hemorrhage due to X-linked GATA1 gene mutation. ( 29949202 )
2018
44
Inflammatory Profiles of the Interleukin Family and Network in Cerebral Hemorrhage. ( 30027390 )
2018
45
Impact of Supratentorial Cerebral Hemorrhage on the Complexity of Heart Rate Variability in Acute Stroke. ( 30065287 )
2018
46
SP100B Expression Indexed Hemorrhage in Mouse Models of Cerebral Hemorrhage. ( 30072838 )
2018
47
Acute Blood Pressure Management in Acute Ischemic Stroke and Spontaneous Cerebral Hemorrhage. ( 30121736 )
2018
48
A Case of a Pregnant Woman with Thrombosis in an Artificial Aortic Valve Resulting in Severe Cerebral Hemorrhage in the Newborn. ( 30151288 )
2018
49
Catastrophic cerebral hemorrhage and edema in a patient with pneumococcal meningitis. ( 30216857 )
2018
50
Comparison of Thrombelastography (TEG) in Patients with Acute Cerebral Hemorrhage and Cerebral Infarction. ( 30217969 )
2018

Variations for Cerebral Hemorrhage

Expression for Cerebral Hemorrhage

Search GEO for disease gene expression data for Cerebral Hemorrhage.

Pathways for Cerebral Hemorrhage

Pathways related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.97 APP CST3 GFAP
2 11.11 KLK1 MMP9
3 10.84 APOB MMP9
4 10.46 APP MMP9
5 10.16 APP CST3 MMP9

GO Terms for Cerebral Hemorrhage

Cellular components related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.72 APOB APP CST3 KLK1 MMP9
2 endoplasmic reticulum lumen GO:0005788 9.43 APOB APP CST3
3 tertiary granule lumen GO:1904724 9.37 CST3 MMP9
4 smooth endoplasmic reticulum GO:0005790 9.16 APOB APP
5 endosome lumen GO:0031904 8.96 APOB APP
6 astrocyte projection GO:0097449 8.62 APP GFAP

Biological processes related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 post-translational protein modification GO:0043687 9.33 APOB APP CST3
2 cholesterol metabolic process GO:0008203 9.26 APOB APP
3 cellular protein metabolic process GO:0044267 9.13 APOB APP CST3
4 extracellular matrix organization GO:0030198 8.8 APP GFAP MMP9

Molecular functions related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 identical protein binding GO:0042802 8.92 APP CST3 GFAP MMP9

Sources for Cerebral Hemorrhage

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....